Commercial Banking 11 min read Updated August 2026

AI for Financial Regulatory Reporting: Basel III Capital, CCAR, and Bank Examination with Claude (2026)

How bank finance teams use Claude AI for regulatory reporting: Basel III CET1, Tier 1, and Total Capital ratio computation with RWA calculation, CCAR/DFAST stress test narrative drafting, regulatory examination MRA response planning, and capital optimization strategy.

Financial Regulatory Reporting and AI

Bank regulatory reporting is one of the most documentation-intensive areas of finance. A mid-size regional bank produces hundreds of regulatory reports annually — call reports, CCAR/DFAST stress tests, Basel III capital calculations, supervisory exam responses, and model validation documentation. Claude with ClaudeFinLab helps bank finance teams structure the computations, draft the narrative sections, and prepare for regulatory examination.

Basel III Capital Ratio Computation

  • "Compute Basel III capital ratios for this regional bank: CET1 capital (common stock + retained earnings - goodwill - intangibles - deferred tax assets above threshold): $1.42B. Additional Tier 1 (preferred stock): $0.15B. Tier 2 (qualifying subordinated debt + ALLL up to 1.25% of RWA): $0.28B. Total capital: $1.85B. Risk-weighted assets: $12.8B (credit RWA $10.2B, market risk RWA $0.8B, operational risk RWA $1.8B). CET1 ratio: $1.42B / $12.8B = 11.1% (vs regulatory minimum 4.5%, well-capitalized minimum 6.5%). Tier 1 ratio: $1.57B / $12.8B = 12.3%. Total capital ratio: $1.85B / $12.8B = 14.5%. Leverage ratio: Tier 1 $1.57B / Total average assets $16.5B = 9.5% (vs 4.0% minimum). Capital adequacy: well-capitalized on all measures."
  • "Compute the regulatory capital impact of acquiring a $2B loan portfolio: the acquisition adds $2B in loans (credit RWA calculation needed). Loan types: commercial real estate ($1.2B, RW 100%), commercial and industrial ($0.5B, RW 100%), residential mortgage ($0.3B, RW 50% under standardized approach). Incremental RWA: $1.2B + $0.5B + $0.15B = $1.85B. New total RWA: $12.8B + $1.85B = $14.65B. Funded by: $1.8B deposits (doesn't affect capital) + $200M Tier 2 subordinated notes (adds $200M Tier 2). New CET1 ratio: $1.42B / $14.65B = 9.7% (declines from 11.1% — still well-capitalized). New Total capital ratio: ($1.85B + $0.2B) / $14.65B = 14.0%."

CCAR/DFAST Stress Test Narrative

  • "Draft the CCAR stress test executive summary narrative: Fed Severely Adverse Scenario: GDP -8.5% peak-to-trough, unemployment 10.2% (peak), S&P 500 -55%, residential home prices -28%, commercial real estate -40%, 3-month Treasury yield near 0%. Under this scenario, our bank's projections: (1) Pre-provision net revenue (PPNR) $485M over 9 quarters (vs baseline $820M — $335M stress impact from NIM compression and fee income decline); (2) Total net charge-offs $680M (vs $180M baseline — elevated from commercial real estate losses $320M, C&I losses $210M, consumer credit $150M); (3) Resulting net income: -$195M loss over 9 quarters. (4) CET1 ratio at minimum: 7.8% (Quarter 5). All capital ratios remain above well-capitalized thresholds throughout. No capital action restrictions required."

Regulatory Examination Response

  • "Draft a response to an OCC Matters Requiring Attention (MRA) on CECL model governance: MRA finding: 'The Bank's CECL model lacks adequate documentation of the reasonable and supportable forecast horizon selection methodology. The Bank's 2-year forecast horizon was not supported by formal analysis of the bank's portfolio characteristics.' Response plan: (1) Immediate action (60 days): commission a study comparing 1-year, 2-year, and 3-year forecast horizons against the bank's loan portfolio mean reversion characteristics, using 10-year historical data. (2) Documentation update (90 days): update CECL model documentation with: (a) quantitative analysis supporting the 2-year horizon selection; (b) sensitivity analysis showing ALLL impact at 1-year and 3-year horizons; (c) governance committee approval. (3) Board reporting: present findings to the Audit Committee at the Q3 meeting. Attach proposed timeline and responsible officers."

Capital Optimization Strategy

  • "Identify capital optimization opportunities: current CET1 ratio 11.1% vs peers (median 10.2%) — we are over-capitalized by ~90bps relative to peers. Excess capital above 10.5% target: ($1.42B - ($12.8B × 10.5%)) = $76M. Capital return options: (1) Special dividend: $76M / 42M shares = $1.81/share special dividend; (2) Buyback: repurchase 2.8M shares at current price $27 = $75.6M (reduces share count 6.7%). EPS impact of buyback: current EPS $2.10, new EPS $2.25 (7.1% accretive). Compare: buyback accretive if earnings yield (2.10/27 = 7.8%) > after-tax cost of any debt issued (none needed — funded from excess capital). Recommend: buyback is preferred for EPS accretion; submit for CCAR capital plan approval."

Where to Start

For regulatory capital analysis, start with the CET1 ratio computation: list CET1 eligible capital components, deductions (goodwill, intangibles, DTAs over threshold), and total risk-weighted assets. Ask Claude to compute all four Basel III ratios (CET1, Tier 1, Total Capital, Leverage). For CCAR, describe the key drivers of your PPNR and credit losses under the severely adverse scenario, and ask Claude to structure the 9-quarter projection and draft the executive summary narrative.